Listed pharmaceutical major The ACME Laboratories Limited (DSE: ACMELAB) has reported a net increase of BDT 80,31,93,206 (approx. BDT 80.32 crore) in the net book value of its fixed assets following a formal revaluation of its property, plant, and equipment.
According to corporate disclosures published on the Dhaka Stock Exchange (DSE) and Chittagong Stock Exchange (CSE) websites on Tuesday (October 27, 2026), the company's Board of Directors approved the asset revaluation report during its board meeting held on Monday (October 26). Independent chartered accountancy firm M M Rahman & Co. Chartered Accountants conducted the valuation exercise. The revaluation scope focused strictly on core land, buildings, plant, and machinery, while excluding furniture and fixtures.
As of June 30, 2026, the valuation exercise determined a gross value appreciation of BDT 81,28,69,698 across appreciated assets, alongside a minor value reduction of BDT 96,76,492 in certain asset categories, resulting in the net surplus of BDT 80.32 crore. ACME Laboratories confirmed that this net revaluation surplus has been duly recognized and accounted for in the audited financial statements for the fiscal year ending June 30, 2026.
— Daily Best News Desk • Fearless in the search for truth
Reported by Staff Reporter • Edited by the Daily Best News desk. Send corrections to [email protected].
